Pathogenic Mouse Hepatitis Virus or Poly(I:C) Induce IL-33 in Hepatocytes in Murine Models of Hepatitis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathogenic Mouse Hepatitis Virus or Poly(I:C) Induce IL-33 in Hepatocytes in Murine Models of Hepatitis
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 9, Pages e74278
Publisher
Public Library of Science (PLoS)
Online
2013-09-14
DOI
10.1371/journal.pone.0074278
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis
- (2012) Muhammad Imran Arshad et al. HEPATOLOGY
- Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists
- (2012) S. K. Polumuri et al. JOURNAL OF IMMUNOLOGY
- Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis B
- (2012) Juan Wang et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology
- (2012) Muhammad I. Arshad et al. LIVER INTERNATIONAL
- Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis C
- (2012) Juan Wang et al. MEDIATORS OF INFLAMMATION
- The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses
- (2012) W. V. Bonilla et al. SCIENCE
- Infection with Influenza Virus Induces IL-33 in Murine Lungs
- (2011) Ronan Le Goffic et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Invariant natural killer T-cell-deficient mice display increased CCl4-induced hepatitis associated with CXCL1 over-expression and neutrophil infiltration
- (2011) Mariette Lisbonne et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis
- (2011) Muhammad I. Arshad et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Autoimmune hepatitis-like disease in C57BL/6 mice infected with mouse hepatitis virus A59
- (2011) José L. Aparicio et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium
- (2011) Lili Zhang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Protective role of IL-33/ST2 axis in Con A-induced hepatitis
- (2011) Vladislav Volarevic et al. JOURNAL OF HEPATOLOGY
- Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity
- (2011) Ya-Jen Chang et al. NATURE IMMUNOLOGY
- Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts
- (2010) Jon Sponheim et al. AMERICAN JOURNAL OF PATHOLOGY
- Intrahepatic endothelial and Kupffer cells involved in immunosuppressive cytokines and natural killer (NK)/NK T cell disorders in viral acute hepatitis
- (2010) A. Jacques et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- High Levels of Soluble ST2 and Low Levels of IL-33 in Sera of Patients with HIV Infection
- (2010) Tomomitsu Miyagaki et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Up-Regulation of Interleukin 33 and Soluble ST2 Serum Levels in Liver Failure
- (2010) Georg A. Roth et al. JOURNAL OF SURGICAL RESEARCH
- Macrophage interleukin-6 and tumour necrosis factor-α are induced by coronavirus fixation to Toll-like receptor 2/heparan sulphate receptors but not carcinoembryonic cell adhesion antigen 1a
- (2009) Alexandre Jacques et al. IMMUNOLOGY
- Interleukin-33 overexpression is associated with liver fibrosis in mice and humans
- (2009) Pierrick Marvie et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in d-galactosamine-sensitized mice
- (2008) Lien Dejager et al. CYTOKINE
- Elevated levels of soluble ST2 protein in dengue virus infected patients
- (2008) Aniuska Becerra et al. CYTOKINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started